Canada markets closed

Sun Pharmaceutical Industries Limited (SUNPHARMA.NS)

NSE - NSE Real Time Price. Currency in INR
Add to watchlist
1,459.80+0.70 (+0.05%)
At close: 03:29PM IST
Currency in INR

Valuation Measures4

Market Cap (intraday) 3.50T
Enterprise Value 3.34T
Trailing P/E 36.59
Forward P/E 26.67
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)7.34
Price/Book (mrq)5.50
Enterprise Value/Revenue 6.98
Enterprise Value/EBITDA 24.02

Trading Information

Stock Price History

Beta (5Y Monthly) 0.53
52-Week Change 344.71%
S&P500 52-Week Change 323.49%
52 Week High 31,638.85
52 Week Low 3977.30
50-Day Moving Average 31,538.56
200-Day Moving Average 31,352.15

Share Statistics

Avg Vol (3 month) 32.84M
Avg Vol (10 day) 34.47M
Shares Outstanding 52.4B
Implied Shares Outstanding 62.43B
Float 81.06B
% Held by Insiders 154.69%
% Held by Institutions 127.10%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 412.5
Forward Annual Dividend Yield 40.86%
Trailing Annual Dividend Rate 313.50
Trailing Annual Dividend Yield 30.93%
5 Year Average Dividend Yield 40.94
Payout Ratio 431.33%
Dividend Date 3N/A
Ex-Dividend Date 4Feb 09, 2024
Last Split Factor 22:1
Last Split Date 3Jul 29, 2013

Financial Highlights

Fiscal Year

Fiscal Year Ends Mar 31, 2024
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 19.75%
Operating Margin (ttm)20.37%

Management Effectiveness

Return on Assets (ttm)7.84%
Return on Equity (ttm)15.20%

Income Statement

Revenue (ttm)484.97B
Revenue Per Share (ttm)202.06
Quarterly Revenue Growth (yoy)9.60%
Gross Profit (ttm)N/A
EBITDA 129.87B
Net Income Avi to Common (ttm)95.76B
Diluted EPS (ttm)39.85
Quarterly Earnings Growth (yoy)33.80%

Balance Sheet

Total Cash (mrq)191.05B
Total Cash Per Share (mrq)79.89
Total Debt (mrq)32.74B
Total Debt/Equity (mrq)4.88%
Current Ratio (mrq)2.56
Book Value Per Share (mrq)266.22

Cash Flow Statement

Operating Cash Flow (ttm)121.35B
Levered Free Cash Flow (ttm)75.42B